If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThg Regulatory News (THG)

Share Price Information for Thg (THG)

Share Price is delayed by 15 minutes
Get Live Data
31.38    -0.22 (-0.70%)
Bid:
31.14
Ask:
31.42
Spread: 0.28 (0.899%)
Market Cap: £497.95m
THG Live PriceLast checked at - London Stock Exchange

Intraday Thg Share Chart

Equity Raise Post-Transaction Report

15 Oct 2024 16:29

RNS Number : 2983I
THG PLC
15 October 2024
 

 

 

For immediate release

 

 

15 October 2024

THG PLC

Equity Raise Post-Transaction Report

 

In accordance with the Statement of Principles (November 2022) published by the Pre-Emption Group, THG PLC ("THG", the "Company"), announces the following post transaction report in connection with the Company's non-pre-emptive issue of equity securities, as announced on 11 October 2024.

 

Terms defined in the placing announcement issued on 10 October 2024 (the "Placing Announcement") have the same meanings in this announcement unless the context provides otherwise.

 

Name of Issuer

THG PLC

Transaction Details

The Company issued 194,722,333 new Ordinary Shares in total pursuant to the Fundraise (comprising 138,265,306 Placing Shares, 45,408,163 Subscription Shares and 11,048,864 Retail Offer Shares), representing approximately 14.6% of the Company's existing issued Ordinary Shares prior to the Fundraise.

 

Settlement and admission of the Placing Shares, the Subscription Shares and the Retail Offer Shares took place at 8.00 am on 15 October 2024.

Use of Proceeds

As set out in the Placing Announcement and the result of placing announcement issued on 11 October 2024, approximately £75 million of net institutional proceeds of the Fundraise will be used to provide IngenuityCo with sufficient medium-term funding (in tandem with appropriate standalone debt issuance plans) and the net proceeds raised in excess of £75 million will be used for general corporate purposes.

Quantum of Proceeds

The aggregate proceeds from the Fundraise amounted to approximately £95.4 million.

 

Discount

The Placing Price of 49 pence represented a discount of approximately 5.2 per cent. to the closing price on 10 October 2024.

Allocations

Soft pre-emption has been adhered to in the allocations process, where possible. Management was involved in the allocations process, which has been carried out in compliance with the MIFID II Allocation requirements.

Consultation

The Company consulted with a number of its major shareholders prior to the Fundraise, with certain of the Company's long-term shareholders indicating their intention to subscribe for, in aggregate, £33 million of new Ordinary Shares at the Placing Price pre-launch as set out in the Placing Announcement.

Retail Investors

The Fundraise included a Retail Offer via the PrimaryBid platform, for a total of 11,048,864 Retail Offer Shares, raising gross proceeds of approximately £5.4 million.

 

Retail investors, who participated in the Retail Offer, were able to do so at the same Placing Price as all other investors participating in the Fundraise.

 

The Retail Offer was made available to existing shareholders and new investors in the UK. Investors were able to participate through PrimaryBid's platform via its partner network (covering 60+ FCA registered intermediaries) and through PrimaryBid's free-to-use direct channel. Investors had the ability to participate in this transaction through ISAs and SIPPs, as well as General Investment Accounts (GIAs). This combination of participation routes meant that, to the extent practicable on the transaction timetable, eligible UK retail investors (including certificated retail shareholders) had the opportunity to participate in the Capital Raise alongside institutional investors.

 

 

 

 

For further information, please contact:

 

Investor Enquiries:

Greg Feehely, SVP Investor Relations

Kate Grimoldby, Director of Investor Relations and Strategic Projects

Investor.Relations@thg.com

Media enquiries:

 

Sodali & Co - Financial PR adviser

Victoria Palmer-Moore / Russ Lynch

+44 (0)20 7250 1446

thg@sodali.com

THG PLC

Viki Tahmasebi

Viki.tahmasebi@thg.com

Barclays (Joint Global Coordinator, Joint Bookrunner and Joint Corporate Broker):

Alastair Blackman

Dominic Harper

Callum West

+44 (0)20 7623 2323

Jefferies International Limited (Joint Global Coordinator, Joint Bookrunner and Joint Corporate Broker):

Philip Noblet

Ed Matthews

Gavriel Lambert

+44 (0)20 7029 8000

Peel Hunt LLP (Joint Bookrunner) George Sellar Sohail Akbar Andrew Clark

+44 (0)20 7418 8900

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEFFAFIIELSEES
Date   Source Headline
25th May 20117:00 amRNSHalf Yearly Report
23rd May 201112:16 pmRNSNotice of Results
19th May 20117:00 amRNSRe Joint Venture
18th May 20117:00 amRNSSite acquisition and appointment
11th Apr 20117:00 amRNSResidential Update
30th Mar 20119:09 amRNSNotification of Awards under PSP
25th Mar 20117:00 amRNSLettings
1st Mar 20116:08 pmRNSResult of AGM
8th Dec 20107:01 amRNSPRELIMINARY RESULTS FOR THE PERIOD ENDED 30 SEPT
8th Dec 20107:00 amRNSDirectorate Change
6th Dec 20107:00 amRNSDisposal
3rd Dec 201011:05 amRNSNotice of Results
4th Nov 20107:00 amRNSCONSTRUCTION OF NORTHERN DESIGN CENTRE COMMENCES
27th Oct 20107:00 amRNSDevelopment Agreement
27th Oct 20107:00 amRNSDevelopment Agreement
6th Oct 20107:00 amRNSDevelopment agreement
17th Sep 20107:00 amRNSSALE AND DEVELOPMENT DEAL AGREED
3rd Sep 20109:40 amRNSChange of Year End
2nd Sep 20107:00 amRNSVesting of Performance Shares
26th Aug 20107:00 amRNSAmendments to Performance Share Plan
29th Jun 20103:04 pmRNSDirector/PDMR Shareholding
29th Jun 20107:00 amRNSHalf Year Results
14th Jun 20101:00 pmRNSNotice of Results
3rd Jun 20105:12 pmRNSDirectorate Change
1st Jun 20107:00 amRNSOpening of Manchester office
7th May 20107:00 amRNSLettings
30th Apr 20108:10 amRNSHolding(s) in Company
20th Apr 20105:55 pmRNSDirector/PDMR Shareholding
20th Apr 20103:31 pmRNSResult of AGM
8th Apr 20103:57 pmRNSDirector/PDMR Shareholding
19th Mar 20104:14 pmRNSPosting of Annual Report & Accounts and AGM Notice
10th Mar 20107:01 amRNSFinal Results
10th Mar 20107:00 amRNSAcquisition
1st Mar 201011:36 amRNSNotice of Results
19th Feb 20107:00 amRNSLetting and planning update
27th Nov 20097:00 amRNSDisposal
23rd Nov 20097:00 amRNSRefinancing Update
6th Nov 20093:27 pmRNSDirector/PDMR Shareholding
26th Oct 20097:00 amRNSForward Funding Agreement
22nd Sep 20095:19 pmRNSDirector/PDMR Shareholding
31st Jul 20094:30 pmRNSInterim Report Posting
31st Jul 20097:00 amRNSAcquisition
20th Jul 20097:00 amRNSLettings
14th Jul 20097:00 amRNSInterim Results
10th Jul 20097:00 amRNSPortfolio activity update
7th Jul 20099:14 amRNSNotice of Results
29th Jun 20098:30 amRNSLetting
29th Jun 20097:00 amRNSLetting
21st May 20097:00 amRNSAppointment of Group Treasurer
30th Apr 20097:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.